Analyst Ratings for Rexnord Corp. (RXN)Updated: 2017-07-27
Rexnord Corp. (NYSE:RXN) was awarded an average rating of Overweight from investment analysts following the stock. About 30 days ago, RXN was issued an average rating of Overweight.
Of the 9 analysts covering the stock, 5 gave it a buy rating, 1 issued an overweight rating, 1 issued a hold rating, 1 issued an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
A number of analysts gave price targets for RXN. The most optimistic analyst gave a price target of 27, implying potential capital gains of 15.88 percent. The lowest price target was 18, which equates to a potential downside of -22.75 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -3.7 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -7.14 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -1.17 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -4.89 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 1 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, compared to 1 analysts that revised their FY estimates downwards.
Analysts estimate earnings of RXN to grow at a rate of 88.49 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of RXN is 0.41.
In the trailing 52-weeks, RXN hit 25.00 at the highest peak, while it's lowest trading point was 15.80. Today's price is 47.47 percent above the 52-week low, and below the high by 6.8 percent. RXN has a price/earnings ratio of 35.85. Investors typically compare the P/E ratio to a company's peers in the industry. The RXN value stock report compares RXN to some of its peers using value stock charts. The market cap of RXN is $2.48 billion. RXN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.